Redirecting to https://vhio.net/2025/12/08/ash-2025-safety-and-efficacy-data-from-a-phase-1-study-show-promise-of-next-generation-car-t-cell-therapy-in-patients-with-refractory-b-cell-acute-lymphoblastic-leukemia/